Výsledky vyhledávání - "Jaewon Hyung"

Akademický článek

Recent advances in systemic therapy for advanced intrahepatic cholangiocarcinoma

Autor: Changhoon Yoo, Jaewon Hyung, Stephen L. Chan

Publikováno v: Liver Cancer, Pp 1-1 (2023)

Background The incidence of intrahepatic cholangiocarcinoma (IHCCA) is rising around the world. The disease is becoming a major global health issue. Conventionally, most patients with cholangiocarcinoma present with advanced disease and systemic ther

Externí odkaz: https://doaj.org/article/f6244b003b5e423abb3f32c392c179f0

Zobrazit plný text záznamu

Akademický článek

GASTric Cancer HER2 Re-Assessment Study 2 (GASTHER2): HER2 Re-assessment for Initially HER2-Negative Advanced Gastric Cancer Patients after Progression on First-Line Treatment.

Autor: Jaewon Hyung¹, Hyung-Don Kim¹, Min-Hee Ryu¹, Young Soo Park², Meesun Moon¹, Yoon-Koo Kang¹ ykkang@amc.seoul.kr

Publikováno v: Cancer Research & Treatment. Jan2024, Vol. 56 Issue 1, p199-207. 9p.

Zobrazit plný text záznamu

Akademický článek

Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability-High Colon Cancer.

Autor: Jaewon Hyung¹, Eun Jeong Cho^2,3, Jihun Kim⁴, Jwa Hoon Kim¹, Jeong Eun Kim¹, Yong Sang Hong¹, Tae Won Kim¹, Chang Ohk Sung^2,3,4 co.sung@amc.seoul.kr, Sun Young Kim¹ sunyoungkim@amc.seoul.kr

Publikováno v: Cancer Research & Treatment. Oct2022, Vol. 54 Issue 4, p1175-1190. 16p.

Zobrazit plný text záznamu

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy

Autor: Jaewon, Hyung, Hyunseok, Yoon, Chang-Min, Choi, Shinkyo, Yoon, Dae Ho, Lee, Sang-We, Kim, Hyeong-Ryul, Kim, Su Ssan, Kim, Si Yeol, Song, Jae Cheol, Lee

Publikováno v: Journal of Cancer Research and Clinical Oncology.

Whether prior radiotherapy (RT) affects the response of EGFR-mutated non-small cell lung cancer (NSCLC) to EGFR tyrosine kinase inhibitor (TKI) remains elusive.Patients with EGFR-mutated NSCLC treated with EGFR TKIs who recurred after curative treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bff5d7cad0e8cc4c6f8dd282bcbd2b83
https://doi.org/10.1007/s00432-022-04287-5

Zobrazit plný text záznamu

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer

Autor: Jaewon Hyung, Ilhwan Kim, Kyu-pyo Kim, Baek-Yeol Ryoo, Jae Ho Jeong, Myoung Joo Kang, Jaekyung Cheon, Byung Woog Kang, Hyewon Ryu, Ji Sung Lee, Kyung Won Kim, Ghassan K. Abou-Alfa, Changhoon Yoo

Publikováno v: JAMA Oncology. 9:692

ImportanceThe NIFTY trial demonstrated the benefit of treatment with second-line liposomal irinotecan (nal-IRI) plus fluorouracil (FU) and leucovorin (LV) for patients with advanced biliary tract cancer (BTC).ObjectiveTo report the updated efficacy o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b56d0c0fb28f56b58a3c635cd186d400
https://doi.org/10.1001/jamaoncol.2023.0016

Zobrazit plný text záznamu

Analysis of plasma circulating tumor DNA in borderline resectable pancreatic ductal adenocarcinoma treated with neoadjuvant modified FOLFIRINOX: Clinical relevance of DNA damage repair gene alterations

Autor: Dong-Hoon Lim, Jaewon Hyung, Sang Soo Lee, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-Pyo Kim, Changhoon Yoo

Publikováno v: Journal of Clinical Oncology. 41:737-737

737 Background: There is no reliable biomarker to guide treatment for patient with borderline resectable pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant modified (m)FOLFIRINOX. We investigated the role of plasma circulating tumor DNA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d775e89277474c0a1d8443f73a374848
https://doi.org/10.1200/jco.2023.41.4_suppl.737

Zobrazit plný text záznamu

DNA mismatch repair deficiency and outcomes of patients with resectable locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery and postoperative S-1: A sub-analysis of the phase 3 PRODIGY trial

Autor: Jaewon Hyung, Young Soo Park, Hyungwoo Cho, Hyung-Don Kim, Min-Hee Ryu, Yoon-Koo Kang

Publikováno v: Journal of Clinical Oncology. 41:431-431

431 Background: Benefit of perioperative or postoperative chemotherapy for resectable locally advanced gastric cancer (LAGC) with DNA mismatch repair (MMR) deficiency is controversial due to concerns about the potential detrimental effect of perioper

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e91c1076688c159424c89413fe1e293f
https://doi.org/10.1200/jco.2023.41.4_suppl.431

Zobrazit plný text záznamu

Akademický článek

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin.

Autor: Jaewon Hyung¹, Bumjun Kim^1,2, Changhoon Yoo¹ kkp1122@amc.seoul.kr, Kyo-pyo Kim¹ yooc@amc.seoul.kr, Jae Ho Jeong¹, Heung-Moon Chang¹, Baek-Yeol Ryoo¹

Publikováno v: Cancer Research & Treatment. Jul2019, Vol. 51 Issue 3, p901-909. 9p.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání